Emcure Pharmaceuticals Limited has informed the Exchange about appointment of Secretarial Auditors subject to approval of Members in the ensuing Annual General Meeting.
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals' Board has approved the appointment of M/s. SVD & Associates, a Pune-based firm of Company Secretaries, as the company's Secretarial Auditor. The appointment is for a term of 5 consecutive years starting from FY 2025-26. The firm, formed in 2014, is peer-reviewed and serves several listed and multinational companies. The appointment is subject to approval by shareholders at the upcoming Annual General Meeting.
This is a routine compliance-related disclosure with no material impact on shareholders or the stock price. It fulfills a regulatory requirement under SEBI listing rules.